These cell cycle changes are consistent with previous findings that BAP18 promotes NSCLC cell proliferation by transcriptionally activating CCND1 and CCND2, two key regulators of the G1–S transition (30). The gene discussed is CCND2; the disease is non-small cell lung carcinoma.